Gkv Capital Management Co., Inc. Incyte Corp Transaction History
Gkv Capital Management Co., Inc.
- $120 Billion
- Q1 2025
A detailed history of Gkv Capital Management Co., Inc. transactions in Incyte Corp stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 117 shares of INCY stock, worth $7,517. This represents 0.01% of its overall portfolio holdings.
Number of Shares
117Holding current value
$7,517% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
694Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.98 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.37 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.28 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$955 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$645 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...